LINC01108: A Potential Drug Target and Biomarker (G102216342)

Target Name: LINC01108

NCBI ID: G102216342

LINC01108

Other Name(s): long intergenic non-protein coding RNA 1108 | Long intergenic non-protein coding RNA 1108, transcript variant 1 | LncRNA-ES1

LINC01108: A Potential Drug Target and Biomarker

LINC01108 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target or biomarker. It is located on chromosome 6p21.3 and has a length of 231 nucleotides.

LINC01108 is a transcribed RNA molecule that is expressed in various tissues and organs, including the brain, heart, liver, and muscle. It is primarily expressed in the brain, where it is highly expressed in the prefrontal cortical regions.

The function of LINC01108 is not well understood, but it is thought to play a role in the regulation of gene expression. It is expressed in a variety of tissues and organs and has been shown to be involved in the regulation of neural development, differentiation, and survival.

One potential drug target for LINC01108 is the neurodegenerative disease Alzheimer's disease. Alzheimer's disease is a progressive neurodegenerative disorder that is characterized by the accumulation of neurofibrillary tangles and beta-amyloid plaques in the brain. These tangles and plaques are thought to contribute to the neurofibrillary hallmark of the disease, which is the hallmark of Alzheimer's disease.

LINC01108 has been shown to be involved in the regulation of the neurotransmitter dopamine, which is involved in the transmission of signals in the brain. Studies have shown that LINC01108 is a highly expressed RNA molecule in the brain and that it is involved in the regulation of dopamine signaling.

In addition to its potential role in the regulation of dopamine signaling, LINC01108 may also be involved in the regulation of other signaling pathways that are important for brain development and function. For example, it has been shown to be involved in the regulation of the Wnt signaling pathway, which is important for the development and maintenance of neural stem cells.

LINC01108 may also be involved in the regulation of cellular processes that are important for the survival and growth of cells. For example, studies have shown that LINC01108 is involved in the regulation of cell adhesion, which is important for the formation of tissues and organs and for the regulation of embryonic development.

In conclusion, LINC01108 is a long intergenic non-protein coding RNA molecule that has been identified as a potential drug target or biomarker. Its function is not well understood, but it is thought to play a role in the regulation of gene expression and cellular processes that are important for brain development and function. Further research is needed to determine the exact function of LINC01108 and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1108

The "LINC01108 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01108 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets